These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37902266)

  • 21. [Clinical characteristics and prognostic analysis of advanced-stage extranodal NK/T cell lymphoma].
    Wei C; Zhang Y; Wang W; Zhang L; Zhang W; Zhou DB
    Zhonghua Xue Ye Xue Za Zhi; 2020 Jun; 41(6):462-468. PubMed ID: 32654458
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison of the clinical efficacies of two L-asparaginase-based chemotherapy regimens for newly diagnosed nasal-type extranodal NK/T-cell lymphoma.
    Wu W; Ren K; Chen X; Li N; Luo Q; Hai T; Zhou H; Zou L
    Cancer Med; 2023 Apr; 12(8):9458-9470. PubMed ID: 37000008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A controlling nutritional status score is an independent predictor for patients with newly diagnosed nasal-type extranodal NK/T-cell lymphoma based on asparaginase-containing regimens.
    Wu W; Ren K; Chen X; Li N; Zhou H; Jiang M; Yu Y; Zou L
    Cancer Med; 2023 Apr; 12(8):9439-9448. PubMed ID: 36866811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary cutaneous NK/T-cell lymphoma, nasal type and CD56-positive peripheral T-cell lymphoma: a cellular lineage and clinicopathologic study of 60 patients from Asia.
    Takata K; Hong ME; Sitthinamsuwan P; Loong F; Tan SY; Liau JY; Hsieh PP; Ng SB; Yang SF; Pongpruttipan T; Sukpanichnant S; Kwong YL; Hyeh Ko Y; Cho YT; Chng WJ; Matsushita T; Yoshino T; Chuang SS
    Am J Surg Pathol; 2015 Jan; 39(1):1-12. PubMed ID: 25188863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cutaneous extranodal natural killer/T-cell lymphoma: a comparative clinicohistopathologic and survival outcome analysis of 45 cases according to the primary tumor site.
    Lee WJ; Jung JM; Won CH; Chang SE; Choi JH; Chan Moon K; Park CS; Huh J; Lee MW
    J Am Acad Dermatol; 2014 Jun; 70(6):1002-9. PubMed ID: 24629518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Clinical Features and Survival Outcome of 107 Newly Diagnosed Advanced Stage Extranodal NK/T-Cell Lymphoma Cases: A Triple-Center Study.
    Li J; Li J; Zhong M; Zhou H; Yu B
    Cancer Manag Res; 2021; 13():1541-1549. PubMed ID: 33623433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nomograms based on SUVmax of
    Li H; Shao G; Zhang Y; Chen X; Du C; Wang K; Gao Z
    Cancer Imaging; 2021 Jan; 21(1):9. PubMed ID: 33419476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Central nervous system involvement at initial diagnosis of extranodal NK/T-cell lymphoma: a retrospective study of a consecutive 12-year case series.
    Wu W; Ren K; Li N; Luo Q; Zhou H; Hai T; Zou L
    Ann Hematol; 2023 Apr; 102(4):829-839. PubMed ID: 36729147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD30 expression is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type.
    Li P; Jiang L; Zhang X; Liu J; Wang H
    BMC Cancer; 2014 Nov; 14():890. PubMed ID: 25429803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term outcomes of patients treated with an EPOCHL regimen as first-line chemotherapy for newly diagnosed extranodal natural killer/T-cell lymphoma: a retrospective single-center study.
    Wei L; Wang J; Ye J; Yang L; Cong J; Li X; Wu Y; Cui X; Ding J; Yao N; Yang J
    Leuk Lymphoma; 2020 Feb; 61(2):337-343. PubMed ID: 31517553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term outcomes and central nervous system relapse in extranodal natural killer/T-cell lymphoma.
    Miyazaki K; Suzuki R; Oguchi M; Taguchi S; Amaki J; Maeda T; Kubota N; Maruyama D; Terui Y; Sekiguchi N; Takizawa J; Tsukamoto H; Murayama T; Ando T; Matsuoka H; Hasegawa M; Wada H; Sakai R; Kameoka Y; Tsukamoto N; Choi I; Masaki Y; Shimada K; Fukuhara N; Utsumi T; Uoshima N; Kagami Y; Asano N; Ejima Y; Katayama N; Yamaguchi M
    Hematol Oncol; 2022 Oct; 40(4):667-677. PubMed ID: 35142384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Efficacy and safety analysis of P-GemDOx regimen and stratified prognosis in patients with early extranodal NK/T cell lymphoma].
    Xing TY; Wang WT; Shen HR; Wu JZ; Yin H; Li Y; Wang L; Liang JH; Li JY; Xu W
    Zhonghua Xue Ye Xue Za Zhi; 2024 Feb; 45(2):163-169. PubMed ID: 38604793
    [No Abstract]   [Full Text] [Related]  

  • 33. A modified international prognostic index including pretreatment hemoglobin level for early stage extranodal natural killer/T cell lymphoma.
    Wang L; Xia ZJ; Lu Y; Wang QX; Niu SQ; Huang HQ; Zhang YJ
    Leuk Lymphoma; 2015; 56(11):3038-44. PubMed ID: 25747971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Long-term effect of risk-adaptive therapy for early stage extranodal NK/T cell lymphoma].
    Wu T; Liu QL; Hu YF; Zhang J; Chen MX; Chen XX; Huang YH; Lu B
    Zhonghua Zhong Liu Za Zhi; 2019 Nov; 41(11):859-864. PubMed ID: 31770855
    [No Abstract]   [Full Text] [Related]  

  • 35. Prognostic role of ABO blood type in patients with extranodal natural killer/T cell lymphoma, nasal type: a triple-center study.
    Li YJ; Yi PY; Li JW; Liu XL; Tang T; Zhang PY; Jiang WQ
    Chin J Cancer; 2017 Jul; 36(1):62. PubMed ID: 28756771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical characteristics and survival analysis of primary intestinal extranodal NK/T-cell lymphoma, nasal type].
    Li Y; Wang XJ; Li YN; Wang XH; Shi YQ; Chen M
    Zhonghua Xue Ye Xue Za Zhi; 2020 Oct; 41(10):818-821. PubMed ID: 33190438
    [No Abstract]   [Full Text] [Related]  

  • 37. Extranodal natural killer/T-cell lymphoma with hepatosplenic involvement: a retrospective study of a consecutive 14-year case series.
    Zhang YH; Li Z; Zhao S; Zhang WY; Liu QL; Liu WP; Gao LM
    Ann Hematol; 2023 Oct; 102(10):2803-2813. PubMed ID: 37434096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The value of prognostic nutritional index in nasal-type, extranodal natural killer/T-cell lymphoma.
    Li N; Jiang M; Wu WC; Zou LQ
    Ann Hematol; 2022 Jul; 101(7):1545-1556. PubMed ID: 35635579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic factors of Chinese patients with T/NK-cell lymphoma: a single institution study of 170 patients.
    Xu PP; Wang Y; Shen Y; Wang L; Shen ZX; Zhao WL
    Med Oncol; 2012 Sep; 29(3):2176-82. PubMed ID: 21710236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm.
    Chan JK; Sin VC; Wong KF; Ng CS; Tsang WY; Chan CH; Cheung MM; Lau WH
    Blood; 1997 Jun; 89(12):4501-13. PubMed ID: 9192774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.